Clinical features of xeroderma pigmentosum

Advances in Experimental Medicine and Biology

Volumn 637, Issue , 2008, Pages 10-18

  Hengge, Ulrich R ^a   Emmert, Steffen ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE (PYRIMIDINE DIMER); ISOTRETINOIN; REACTIVE OXYGEN METABOLITE; SUNSCREEN;

ACTINIC KERATOSIS; ANGIOSARCOMA; AREFLEXIA; ASTROCYTOMA; ATAXIA; ATROPHY; AUTOSOMAL RECESSIVE DISORDER; AUTOSOMAL RECESSIVE INHERITANCE; BASAL CELL CARCINOMA; BIOCHEMISTRY; BLEPHARITIS; BLISTER; BRAIN CANCER; CACHEXIA; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RISK; CELL CULTURE; CELL DEATH; CHOREA; CHROMOSOME BREAKAGE; CLINICAL FEATURE; COCKAYNE SYNDROME; CONGENITAL SKIN DISEASE; CONJUNCTIVITIS; CONSANGUINITY; CORNEA DISEASE; CORNEA ULCER; CUTANEOUS PARAMETERS; DE SANCTIS CACCHIONE SYNDROME; DEMYELINATION; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DNA DAMAGE; DNA REPAIR; DNA SYNTHESIS; DWARFISM; DYSARTHRIA; EARLY DIAGNOSIS; ECTROPION; ELECTROMYOGRAM; EPILEPSY; ERYTHEMA; EXCISION REPAIR; EYE DISEASE; FAMILIAL DISEASE; FIBROSARCOMA; GENE SEQUENCE; GENETIC COMPLEMENTATION; GENETIC DISORDER; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GLIOBLASTOMA; HEARING IMPAIRMENT; HETEROZYGOTE; HUMAN; HYPERSENSITIVITY; HYPOGONADISM; HYPOREFLEXIA; ICHTHYOSIS; INCIDENCE; KERATOACANTHOMA; LENTIGO; LEUKEMIA; LIFE EXPECTANCY; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT NEURILEMOMA; MELANOMA; MENTAL DEFICIENCY; MICROCEPHALY; MOTOR DYSFUNCTION; MOUTH TUMOR; MYOPATHY; NERVE CELL DEGENERATION; NERVE CONDUCTION; NEUROLOGIC DISEASE; NYSTAGMUS; ONSET AGE; OXIDATIVE STRESS; PATIENT EDUCATION; PERCEPTION DEAFNESS; PERIPHERAL NEUROPATHY; PHOTOPHOBIA; PHOTOSENSITIVITY; POIKILODERMA; PRENATAL SCREENING; PREVALENCE; PREVENTION AND CONTROL; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCAR FORMATION; SEXUAL DEVELOPMENT; SHORT STATURE; SKIN CANCER; SKIN PIGMENTATION; SKIN PROTECTION; SKIN TUMOR; SPASTICITY; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; SUNBURN; SUNLIGHT; SURVIVAL RATE; SYMBLEPHARON; TELANGIECTASIA; TRICHOTHIODYSTROPHY; VASCULARIZATION; VISUAL IMPAIRMENT; XERODERMA PIGMENTOSUM; XEROSIS;

HUMANS; XERODERMA PIGMENTOSUM;

EID: 60549114732     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-09599-8_2     Document Type: Review

References (27)

1. Jimbo T, Ichihashi M, Mishima Y ct al. Role of excision repair in UVB-induced depletion and recovery of human epidermal Langcrhans cells. Arch Dermatol 1992; 128:61-67.
2. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular and neurologic abnormalities in 830 published cases. Arch Dermatol 1987; 123:241-250.
3. Goyal JL, Rao VA, Srinivasan R et al. Oculocutaneous manifestations in xeroderma pigmentosa. Br J Ophthalmol 1994; 78:295-297.
4. English JS, Swerdlow AJ. The risk of malignant melanoma, internal malignancy and mortality in xeroderma pigmentosum patients. Br J Dermatol 1987; 117:457-461.
5. Kobayashi M, Satoh Y, Irimajiri T et al. Skin tumors of xeroderma pigmentosum (I). J Dermatol 1982; 9:319-322.
6. Kraemer KH, Lee MM, Scotto J. Early onset of skin and oral cavity neoplasms in xeroderma pigmentosum. Lancet 1982; 1:56-57.
7. van Steeg H, Mullenders LH, Vijg J. Mutagenesis and carcinogenesis in nucleotide excision repair-deficient XPA knock out mice. Mutat Res 2000; 450:167-180.
8. Morison WL, Bucana C, Hashem N et al. Impaired immune function in patients with xeroderma pigmentosum. Cancer Res 1985; 45:3929-3931.
9. De Silva BD, Nawroz I, Doherty VR. Angiosarcoma of the head and neck associated with xeroderma pigmentosum variant. Br J Dermatol 1999; 141:166-167.
10. Schroeder TM. Relationship between chromosomal instabihty and leukemia. Hamatol Bluttransfus 1974; 14:94-96.
11. Hakamada S, Watanabe K, Sobue G et al. Xeroderma pigmentosum: neurological, neurophysiological and morphological studies. Eur Neurol 1982; 21:69-76.
12. Robbins JH. Xeroderma pigmentosum. Defective DNA repair causes skin cancer and neurodegeneration. JAMA 1988; 260:384-388.
13. Robbins JH, Brumback RA, Moshell AN. Clinically asymptomatic xeroderma pigmentosum neurological disease in an adult: evidence for a neurodegeneration in later life caused by defective DNA repair. Eur Neurol 1993; 33:188-190.
14. Rolig RL, McKinnon PJ. Linking DNA damage and neurodegeneration. Trends Neurosci 2000; 23:417-424.
15. Mimaki T, Itoh N, Abe J et al. Neurological manifestations in xeroderma pigmentosum. Ann Neurol 1986; 20:70-75.
16. Nakamura T, Ono T, Yoshimura K et al. Malignant schwannoma associated with xeroderma pigmentosum in a patient belonging to complementation group D. J Am Acad Dermatol 1991; 25:349-353.
17. De Sanctis C, Cacchione A. L'idiozia xerodermica. Riv Spcr Freniat 1932; 56:269-292.
18. Vivian AJ, ElUson DW, McGill JL Ocular melanomas in xeroderma pigmentosum. Br J Ophthalmol 1993; 77:597-598.
19. Nance MA, Berry SA. Cockayne syndrome: review of 140 cases. Am J Med Genet 1992; 42:68-84.
20. Lehmann AR. DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy Biochimie 2003; 85:1101-1111.
21. Bcrneburg M, Lowe JE, Nardo T et al. UV damage causes uncontrolled DNA breakage in cells from patients with combined features of XP-D and Cockayne syndrome. EMBO J 2000; 19:1157-1166.
22. Broughton BC, Berneburg M, Fawcett H et al. Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene. Hum Mol Genet 2001; 10:2539-2347.
23. Scott RJ, Itin P, Klcijer WJ et al. Xeroderma pigmentosum-Cockayne syndrome complex in two patients: absence of skin tumors despite severe deficiency of DNA excision repair. J Am Acad Dermatol 1993; 29:883-889.
24. Itin PH, Sarasin A, Pittelkow MR. Trichothiodystrophy: update on the sulfiir-deficient brittle hair syndromes. J Am Acad Dermatol 2001; 44:891-920.
25. Kraemer KH, DiGiovanna JJ, Moshell AN et al. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 1988; 318:1633-1637.
26. Yarosh D, Klein J, O'Connor A et al. Efiect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group. Lancet 2001; 357:926-929.
27. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular and neurologic abnormalities in 830 published cases. Arch Dermatol 1987; 123:241-50.